Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on October 1, 2026

11 hours ago

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Indeterminate GlobeNewswire

11 hours ago

Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care

Indeterminate GlobeNewswire

11 hours ago

Crohn et Colite Canada investit 1,5 million de dollars dans la recherche sur les MII et les soins futurs

Indeterminate GlobeNewswire

11 hours ago

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Indeterminate GlobeNewswire

11 hours ago

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

Indeterminate GlobeNewswire

11 hours ago

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

Indeterminate GlobeNewswire

11 hours ago

American Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease Legislation

Indeterminate GlobeNewswire

11 hours ago

Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting

Indeterminate GlobeNewswire

11 hours ago

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

Indeterminate GlobeNewswire

11 hours ago

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

11 hours ago

AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients

Indeterminate GlobeNewswire

11 hours ago

Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.

Indeterminate GlobeNewswire

11 hours ago

Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

11 hours ago

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Indeterminate GlobeNewswire

11 hours ago

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Indeterminate GlobeNewswire

11 hours ago

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

Indeterminate GlobeNewswire

11 hours ago

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

Indeterminate GlobeNewswire

11 hours ago

Nox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada

Indeterminate GlobeNewswire

11 hours ago

PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities

Indeterminate GlobeNewswire

11 hours ago

Health-ISAC® Director of European Operations Elected European Council of ISACs Chair

Indeterminate GlobeNewswire